MERCK

NJ

A research-intensive biopharmaceutical company

Filings
47
Firms Hired
1
Total Expenses
—
Years Active
2015–2026

Filings

All 202620252024202320222021202020192018201720162015
YearFirmPeriodExpensesDoc
2026 TARPLIN, DOWNS & YOUNG, LLC 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		—
2025 TARPLIN, DOWNS & YOUNG, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		—
2025 TARPLIN, DOWNS & YOUNG, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report 		—
2025 TARPLIN, DOWNS & YOUNG, LLC 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		—
2025 TARPLIN, DOWNS & YOUNG, LLC 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		—
2024 TARPLIN, DOWNS & YOUNG, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		—
2024 TARPLIN, DOWNS & YOUNG, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report 		—
2024 TARPLIN, DOWNS & YOUNG, LLC 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		—
2024 TARPLIN, DOWNS & YOUNG, LLC 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		—
2023 TARPLIN, DOWNS & YOUNG, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		—
Page 1 of 5  ·  47 filings Next
Firms Hired
FirmFilingsExpenses
TARPLIN, DOWNS & YOUNG, LLC 47 —
Issue Areas
IssueActivities
Medicare/Medicaid 47
Health Issues 47
Budget/Appropriations 47
Copyright/Patent/Trademark 41
Taxation/Internal Revenue Code 1

Bills Mentioned in Filings

H.R. 5376 S. 1416 H.R. 1839 H.R. 259 S. 637 H.R. 1628 H.R. 749 S. 469 S. 771 H.R. 512 H. CON. RES. 27 H.R. 1470 S. 810 S. CON. RES. 11 H.R. 2 S. 1895 H.R. 2430 S. 204 H.R. 878 H.R. 6 H.R. 9 S. 1137 S. 779 H.R. 1319 S. 2543